Neogen (NEOG) Stock Price, News & Analysis

Company Overview

Neogen Corporation develops and markets products and services designed to protect food, animals and people. The company’s offerings help customers detect, prevent and manage biological, chemical and physical hazards across the food production, agricultural and animal care industries.

Its food safety portfolio includes test kits and related technologies for detecting pathogens, allergens, mycotoxins, spoilage organisms, veterinary drug residues and other contaminants. Neogen also provides sanitation and hygiene products, diagnostic tools, laboratory services, software and training for food manufacturers, processors, retailers and other organizations involved in the food supply chain.

Neogen’s animal safety business serves livestock, poultry, companion animal and veterinary markets. Its products include animal health pharmaceuticals, diagnostics, disinfectants, veterinary instruments, supplements, pest control products and animal genomics services. The company serves customers in North America and international markets through direct operations, distributors and other sales channels.

Founded in 1982 and headquartered in Lansing, Michigan, Neogen expanded its food safety operations through the acquisition of 3M’s Food Safety business, completed in 2022. John Adent serves as the company’s president and chief executive officer.

Key Stats

• Today's Range: $11.68 to $11.98
• 50-Day Range: $9.19 to $12.15
• 52-Week Range: $4.90 to $12.85
• Volume: 1.67 million shs
• Average Volume: 1.78 million shs
• Market Capitalization: $2.57 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $12.00
• Consensus Rating: Hold

Neogen Stock Analysis - MarketRank™

Neogen scored higher than 36% of companies evaluated by MarketBeat, and ranked 749th out of 904 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.7 / 5
• Analyst Rating: Hold

Consensus Rating

Neogen has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on no strong buy ratings, 3 buy ratings, 1 hold rating, and 1 sell rating.

Upside/Downside

The consensus price target for Neogen is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Neogen has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 18.52%

Earnings Growth

Earnings for Neogen are expected to grow by 18.52% in the coming year, from $0.27 to $0.32 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Neogen is -392.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Neogen is -392.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

Neogen has a PEG Ratio of 4.42. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Neogen has a P/B Ratio of 1.23. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

4.87% of the float of Neogen has been sold short.

Short Interest Ratio / Days to Cover

Neogen has a short interest ratio ("days to cover") of 7.41.

Change versus previous month

Short interest in Neogen has recently increased by 6.53%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Neogen does not currently pay a dividend.

Dividend Growth

Neogen does not have a long track record of dividend growth.

News and Social Media

• Score: 2.3 / 5
• News Sentiment: 0.66

News Sentiment

Neogen has a news sentiment score of 0.66. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.89 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 8 news articles for Neogen this week, compared to 6 articles on an average week.

MarketBeat Follows

Only 1 people have added Neogen to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 2.2 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Neogen insiders have bought more of their company's stock than they have sold. Specifically, they have bought $4,370.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

0.46% of the stock of Neogen is held by insiders.

Percentage Held by Institutions

96.73% of the stock of Neogen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 7/30/2026
• Today: 9/13/2026
• Investor Day 2026: 10/07/2026
• Next Earnings (Estimated): 10/08/2026
• Fiscal Year End: 5/31/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Supplies
• Current Symbol: NASDAQ:NEOG
• CIK: 711377
• Web: www.neogen.com
• Phone: (517) 372-9200
• Fax: 517-372-2006
• Employees: 1,257
• Year Founded: 1982

Price Target and Rating

• Average Price Target for Neogen: $12.00
• High Price Target: $14.00
• Low Price Target: $10.00
• Potential Upside/Downside: +1.9%
• Consensus Rating: Hold
• Rating Score (0-4): 2.40
• Research Coverage: 5 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.03)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 43.63
• P/E Growth: 4.42
• Net Income: -$7.90 million
• Net Margins: -0.91%
• Pretax Margin: -1.03%
• Return on Equity: 2.78%
• Return on Assets: 1.74%

Debt

• Debt-to-Equity Ratio: 0.38
• Current Ratio: 3.82
• Quick Ratio: 2.91

Sales & Book Value

• Annual Sales: $870.40 million
• Price / Sales: 2.95
• Cash Flow: $0.84 per share
• Price / Cash Flow: 13.97
• Book Value: $9.61 per share
• Price / Book: 1.23

Miscellaneous

• Outstanding Shares: 218,110,000
• Free Float: 217,103,000
• Market Cap: $2.57 billion
• Optionable: Optionable
• Beta: 1.76